These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30027002)

  • 1. Evaluation of Montelukast for the Treatment of Children With Japanese Cedar Pollinosis Using an Artificial Exposure Chamber (OHIO Chamber).
    Hashiguchi K; Okubo K; Inoue Y; Numaguchi H; Tanaka K; Oshima N; Mehta A; Nishida C; Saito I; Philip G
    Allergy Rhinol (Providence); 2018; 9():2152656718783599. PubMed ID: 30027002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The assessment of the optimal duration of early intervention with montelukast in the treatment of Japanese cedar pollinosis symptoms induced in an artificial exposure chamber.
    Hashiguchi K; Okubo K; Wakabayashi K; Tanaka N; Watada Y; Suematsu K; Gotoh M
    J Drug Assess; 2012; 1(1):40-7. PubMed ID: 27536427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pranlukast dry syrup inhibits symptoms of Japanese cedar pollinosis in children using OHIO Chamber.
    Wakabayashi K; Hashiguchi K; Kanzaki S; Fujioka M; Tanaka N; Kawashima K; Suematsu K; Yamamotoya H; Iwasaki M; Gotoh M; Horibe S; Naito K; Okubo K
    Allergy Asthma Proc; 2012; 33(1):102-9. PubMed ID: 22370535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine antagonist Bepotastine suppresses nasal symptoms caused by Japanese cedar and cypress pollen exposure.
    Kanzaki S; Hashiguchi K; Wakabayashi KI; Suematsu K; Okubo K
    J Drug Assess; 2016; 5(1):15-23. PubMed ID: 27785375
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic effect of bilastine in Japanese cedar pollinosis using an artificial exposure chamber (OHIO Chamber).
    Hashiguchi K; Wakabayashi KI; Togawa M; Saito A; Okubo K
    Allergol Int; 2017 Jan; 66(1):123-131. PubMed ID: 27475625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bepotastine besilate OD tablets suppress nasal symptoms caused by Japanese cedar pollen exposure in an artificial exposure chamber (OHIO Chamber).
    Hashiguchi K; Tang H; Fujita T; Suematsu K; Gotoh M; Okubo K
    Expert Opin Pharmacother; 2009 Mar; 10(4):523-9. PubMed ID: 19216705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo-controlled study with OHIO chamber of prophylactic pranlukast for children with Japanese cedar pollinosis: TOPIC-J III study.
    Hosoya K; Masuno S; Hashiguchi K; Okubo K
    J Drug Assess; 2014; 3(1):51-9. PubMed ID: 27536454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial of pranlukast inhibitory effect for cedar exposure using an OHIO chamber.
    Endo S; Gotoh M; Okubo K; Hashiguchi K; Suzuki H; Masuyama K
    J Drug Assess; 2012; 1(1):48-54. PubMed ID: 27536428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation study of the OHIO Chamber in patients with Japanese cedar pollinosis.
    Hashiguchi K; Tang H; Fujita T; Suematsu K; Tsubaki S; Nagakura H; Kitajima S; Gotoh M; Okubo K
    Int Arch Allergy Immunol; 2009; 149(2):141-9. PubMed ID: 19127071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary study on Japanese cedar pollinosis in an artificial exposure chamber (OHIO Chamber).
    Hashiguchi K; Tang H; Fujita T; Tsubaki S; Fujita M; Suematsu K; Gotoh M; Okubo K
    Allergol Int; 2007 Jun; 56(2):125-30. PubMed ID: 17384532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of fluticasone furoate nasal spray and levocetirizine in patients with Japanese cedar pollinosis subjected to an artificial exposure chamber.
    Hashiguchi K; Kanzaki S; Wakabayashi K; Tanaka N; Kawashima K; Suematsu K; Tokunaga S; Ogawa K; Okubo K
    J Drug Assess; 2013; 2(1):94-105. PubMed ID: 27536443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy and safety of olopatadine and fexofenadine compared with placebo in Japanese cedar pollinosis using an environmental exposure unit.
    Enomoto T; Lu HQ; Yin M; Sakoda T; Dake Y; Enomoto K; Ide T; Cheng L
    J Investig Allergol Clin Immunol; 2009; 19(4):299-305. PubMed ID: 19639726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive biological evaluation of response to pranlukast treatment in pediatric patients with Japanese cedar pollinosis.
    Gotoh M; Okubo K; Hashiguchi K; Wakabayashi K; Kanzaki S; Tanaka N; Fujioka M; Kawashima K; Suematsu K; Sasaki K; Iwasaki M; Yamamotoya H
    Allergy Asthma Proc; 2012; 33(6):459-66. PubMed ID: 23394502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of loratadine-montelukast on nasal congestion in patients with seasonal allergic rhinitis in an environmental exposure unit.
    Day JH; Briscoe MP; Ratz JD; Danzig M; Yao R
    Ann Allergy Asthma Immunol; 2009 Apr; 102(4):328-38. PubMed ID: 19441605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
    Jacobs R; Martin B; Hampel F; Toler W; Ellsworth A; Philpot E
    Curr Med Res Opin; 2009 Jun; 25(6):1393-401. PubMed ID: 19419338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Efficacy and Dose-Finding Trial of Japanese Cedar Pollen Sublingual Immunotherapy Tablet.
    Gotoh M; Yonekura S; Imai T; Kaneko S; Horikawa E; Konno A; Okamoto Y; Okubo K
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1287-1297.e8. PubMed ID: 30537561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis.
    Okamoto Y; Okubo K; Yonekura S; Hashiguchi K; Goto M; Otsuka T; Murata T; Nakao Y; Kanazawa C; Nagakura H; Okawa T; Nakano K; Hisamitsu M; Kaneko S; Konno A
    Int Arch Allergy Immunol; 2015; 166(3):177-88. PubMed ID: 25895909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Desloratadine and Levocetirizine in Patients with Cedar Pollen-Induced Allergic Rhinitis: A Randomized, Double-Blind Study.
    Yonekura S; Okamoto Y; Sakurai D; Iinuma T; Sakurai T; Yoneda R; Kurita J; Hanazawa T; Kawasaki Y
    Int Arch Allergy Immunol; 2019; 180(4):274-283. PubMed ID: 31618733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis.
    Krug N; Gupta A; Badorrek P; Koenen R; Mueller M; Pivovarova A; Hilbert J; Wetzel K; Hohlfeld JM; Wood C
    J Allergy Clin Immunol; 2014 Feb; 133(2):414-9. PubMed ID: 24332218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.
    Di Lorenzo G; Pacor ML; Pellitteri ME; Morici G; Di Gregoli A; Lo Bianco C; Ditta V; Martinelli N; Candore G; Mansueto P; Rini GB; Corrocher R; Caruso C
    Clin Exp Allergy; 2004 Feb; 34(2):259-67. PubMed ID: 14987306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.